Related Experiment Video
Updated: Jul 18, 2026
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Interaction of malaria parasite-inhibitory antibodies with the merozoite surface protein MSP1(19) by computational
Flavia Autore1, Sara Melchiorre, Jens Kleinjung
1Dipartimento di Chimica Organica e Biochimica, Università di Napoli Federico II, Complesso Universitario Monte Sant'Angelo, via Cinthia, 80126, Naples, Italy.
Abstract:
Merozoite surface protein 1 (MSP1) of the malaria parasite Plasmodium falciparum is an important vaccine candidate antigen. Antibodies specific for the C-terminal maturation product, MSP1(19), have been shown to inhibit erythrocyte invasion and parasite growth. Specific monoclonal antibodies react with conformational epitopes contained within the two EGF-like domains that constitute the antigen MSP1(19). To gain greater insight into the inhibitory process, the authors selected two strongly inhibitory antibodies (designated 12.8 and 12.10) and modeled their structures by homology. Computational docking was used to generate antigen-antibody complexes and a selection filter based on NMR data was applied to obtain plausible models. Molecular Dynamics simulations of the selected complexes were performed to evaluate the role of specific side chains in the binding. Favorable complexes were obtained that complement the NMR data in defining specific binding sites. These models can provide valuable guidelines for future experimental work that is devoted to the understanding of the action mechanism of invasion-inhibitory antibodies.
Insights
Antibodies targeting Plasmodium falciparum merozoite surface protein 1 C-terminal (MSP1(19)) inhibit malaria parasite growth. Computational models reveal specific binding sites, guiding future vaccine development for invasion-inhibitory antibodies.
Area of Science:
- Immunology
- Parasitology
- Structural Biology
Background:
- Merozoite surface protein 1 (MSP1) of Plasmodium falciparum is a key malaria vaccine candidate.
- Antibodies against the MSP1(19) C-terminal region inhibit parasite invasion and growth.
- These antibodies recognize conformational epitopes within MSP1(19)'s EGF-like domains.
Purpose of the Study:
- To investigate the molecular mechanisms of invasion-inhibitory antibodies targeting MSP1(19).
- To model antigen-antibody complexes and identify specific binding interactions.
- To provide structural insights for developing effective malaria vaccines.
Main Methods:
- Homology modeling to predict antibody structures (12.8 and 12.10).
- Computational docking to generate antigen-antibody complexes.
- NMR data filtering and Molecular Dynamics simulations to refine binding models.
Main Results:
- Plausible models of antigen-antibody complexes were generated.
- Specific binding sites and side chain interactions were identified.
- Models are consistent with NMR data, defining key binding interactions.
Conclusions:
- The study provides detailed structural models of inhibitory antibodies bound to MSP1(19).
- These models elucidate the molecular basis of antibody-mediated inhibition of parasite invasion.
- The findings offer valuable guidance for rational design of malaria vaccines targeting MSP1.
More Related Videos
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
08:46Myeloid Cell Isolation from Mouse Skin and Draining Lymph Node Following Intradermal Immunization with Live Attenuated Plasmodium Sporozoites
Published on: May 18, 2016
